Omeros gains on OMS103HP data

Omeros Corp. (NASDAQ:OMER) gained $1.01 to $7.04 on Wednesday after reporting data from a Phase II trial of OMS103HP to reduce post-operative pain and improve post-operative joint function and motion ...